NCT06116578 Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab Status WITHDRAWN Phase PHASE2
NCT06116084 Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine Status RECRUITING Phase NA
NCT06112964 Neurobehavioural and Cognitive Changes in Cancer Cachexia (CANCOG) Status RECRUITING Phase N/A
NCT06103279 Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT06098404 Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study Status RECRUITING Phase N/A
NCT06096623 The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment Status RECRUITING Phase NA
NCT06092606 A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients Status RECRUITING Phase PHASE2
NCT06090266 A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents Status RECRUITING Phase PHASE1/PHASE2
NCT06089967 Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy Status COMPLETED Phase N/A
NCT06086990 Effects of Telemonitoring in Quality of Life Amongst Cancer Patients Status RECRUITING Phase NA
NCT06083324 EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer Status RECRUITING Phase N/A
NCT06077110 Precision Care Initiative: Integrating Precision Oncology Into Clinical Programs Status NOT_YET_RECRUITING Phase NA
NCT06074445 Caring for the Sexual Health and Wellbeing of Cancer Survivors and Their Intimate Partners: An Anonymous Survey Status COMPLETED Phase N/A